Home » Actavis Launches Griseofulvin Oral Suspension in the U.S.
Actavis Launches Griseofulvin Oral Suspension in the U.S.
Actavis announced the launch of griseofulvin oral suspension 125 mg/5 mL for fungal infections in the U.S.
According to Actavis, griseofulvin oral suspension is the generic equivalent of Ortho-McNeil’s Grifulvin.
Griseofulvin is indicated for the treatment of fungal infections of the skin, fingernails and toenails, the company added.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May